CN Patent
CN108218928B — 葡萄糖苷的二环衍生物及其制备方法和用途
Assigned to China Resources Double Crane Pharmaceutical Co Ltd · Expires 2020-06-30 · 6y expired
What this patent protects
本发明涉及葡萄糖苷的二环衍生物及其制备方法和用途,具体地,本发明涉及式Ⅰ所示化合物、其立体异构体或药学上可接受的盐或酯,其药物组合物及其用于制备治疗糖尿病或其相关疾病的药物的用途,
USPTO Abstract
本发明涉及葡萄糖苷的二环衍生物及其制备方法和用途,具体地,本发明涉及式Ⅰ所示化合物、其立体异构体或药学上可接受的盐或酯,其药物组合物及其用于制备治疗糖尿病或其相关疾病的药物的用途,
Drugs covered by this patent
- Farxiga (DAPAGLIFLOZIN) · AstraZeneca
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.